Is Stanrose Mafat. overvalued or undervalued?

As of 10 October 2025, the valuation grade for Stanrose Mafat has moved from risky to very expensive. The company is currently considered overvalued. Key ratios indicate significant concerns, with a PE Ratio of -14.63, an EV to EBITDA of -1.39, and a ROE of -5.31%.
In comparison to its peers, Stanrose Mafat's valuation metrics are starkly unfavorable. For instance, Bajaj Finance has a PE Ratio of 36.56, while Life Insurance boasts a PE of 11.65, highlighting the disparity in valuation. Additionally, the company's recent stock performance has been disappointing, with a year-to-date return of -9.32%, contrasting sharply with the Sensex's gain of 5.58% during the same period. This further underscores the overvaluation concern for Stanrose Mafat.